| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000043837 |
| Receipt No. | R000048532 |
| Scientific Title | An Improved Version of Simple Angle-Measuring Instrument for Measuring Cemented Stem Anteversion during Total Hip Arthroplasty |
| Date of disclosure of the study information | 2021/04/08 |
| Last modified on | 2021/04/09 (Ver. 3) |
| Basic information | ||
| Public title | An Improved Version of Simple Angle-Measuring Instrument for Measuring Cemented Stem Anteversion during Total Hip Arthroplasty | |
| Acronym | An Improved Version of Simple Angle-Measuring Instrument for Measuring Cemented Stem Anteversion during Total Hip Arthroplasty | |
| Scientific Title | An Improved Version of Simple Angle-Measuring Instrument for Measuring Cemented Stem Anteversion during Total Hip Arthroplasty | |
| Scientific Title:Acronym | An Improved Version of Simple Angle-Measuring Instrument for Measuring Cemented Stem Anteversion during Total Hip Arthroplasty | |
| Region |
|
|
| Condition | ||
| Condition | osteoarthritis, osteonecrosis of the head, rapidly destructive coxarthrosis, rheumatoid arthritis, and femoral neck fracture | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The objective of this study was to investigate the accuracy of intraoperative measurements of cemented stem anteversion obtained using the improved version of angle-measuring instrument, compared with a conventional angle-measuring instrument. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | measurements of stem anteversion |
| Key secondary outcomes | surgical time, amount of bleeding, Harris hip score, HOOS, complications |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Measurement accuracy was defined as the difference between the intraoperative measurements of stem anteversion obtained using the conventional or improved version of instrument and the postoperative measurements of stem anteversion obtained using postoperative CT. We compare the measurement accuracy in same patient using the conventional or improved version of instrument. Implantation accuracy was defined as the difference between the target stem anteversion using improved version of instrument and the postoperative measurements of stem anteversion obtained using postoperative CT. Intervention period is intraoperative period. We observe the intervention group for 6 months. Control group is the patient that reported previously using conventional instrument. We compare the measurement accuracy in patient using the conventional instrument and improved version of instrument. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The following were required: primary THA, age of 20 years or older, a willingness to participate, | |||
| Key exclusion criteria | Exclusion criteria included revision THA, prior hip surgery, infection, bone defect, metabolic bone disease, contraindications for the use of instrument or other conditions judged to be inadequate for participation in this analysis. | |||
| Target sample size | 149 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Asahikawa Medical University | ||||||
| Division name | Department of orthopaedic surgery | ||||||
| Zip code | 078-8510 | ||||||
| Address | Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido | ||||||
| TEL | 0166682511 | ||||||
| mitutake@asahikawa-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Asahikawa Medical University | ||||||
| Division name | Department of orthopaedic surgery | ||||||
| Zip code | 078-8510 | ||||||
| Address | Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido | ||||||
| TEL | 0166682511 | ||||||
| Homepage URL | |||||||
| mitutake@asahikawa-med.ac.jp | |||||||
| Sponsor | |
| Institute | Asahikawa Medical University
Department of orthopaedic surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Asahikawa Medical University |
| Address | Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido |
| Tel | 0166-68-2297 |
| rs-kk.g@asahikawa-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048532 |